IFNA2 蛋白
-
- 抗原 See all IFNA2 蛋白
- IFNA2 (Interferon, alpha 2 (IFNA2))
- 蛋白类型
- Recombinant
- 生物活性
- Active
-
宿主
- 小鼠
-
资源
- 大肠杆菌（E. Coli）
- 应用范围
- Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunohistochemistry (IHC)
- 纯化方法
- Purified by affinity chromatography.
- 纯度
- > 98 % pure
- 过滤
- Sterile
- 内毒素水平
- < 0.01 ng/μg cytokine as determined by the LAL assay.
- Top Product
- Discover our top product IFNA2 蛋白
-
Interferon, alpha 2 (IFNA2) (Active) protein
IFNA2 宿主: 人 宿主: 大肠杆菌（E. Coli） Recombinant >95 % as determined by SDS-PAGE Func Active
Interferon, alpha 2 (IFNA2) proteinIFNA2 宿主: 小鼠 宿主: 大肠杆菌（E. Coli） Recombinant > 95 % as determined by SDS-PAGE
Interferon, alpha 2 (IFNA2) (AA 24-133) protein (GST tag)IFNA2 宿主: 人 宿主: 小麦胚 Recombinant WB, ELISA, AP, AA
Interferon, alpha 2 (IFNA2) (AA 1-188) protein (GST tag)IFNA2 宿主: 人 宿主: 小麦胚 Recombinant WB, ELISA, AP, AA
Interferon, alpha 2 (IFNA2) (AA 24-188) protein (Fc Tag)IFNA2 宿主: 人 宿主: Mammalian Cells Recombinant The purity of the protein is greater than 95 % as determined by SDS-PAGE and Coomassie blue staining.
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 说明
-
Biological activity: The recombinant mouse IFN- alpha2 has been tested for inhibition of the cytopathic effect of EMC virus onL929 cells. The ED50 for this effect is typically 0.1 ng/mL, corresponding to a specific activity of 1 x 107 U/mg.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 500 μg/mL
- 缓冲液
- Supplied as a sterile liquid with 50 mM NaAc, 0.1 M NaCl, 0.5 % BSA, pH 5.0
- 储存条件
- 4 °C/-20 °C/-80 °C
-
- 抗原
- IFNA2 (Interferon, alpha 2 (IFNA2))
- 别名
- IFNa2 (IFNA2 产品)
- 别名
- IFN-alphaA Protein, IFNA Protein, IFNA2B Protein, INFA2 Protein, Ifa2 Protein, IFNA2 Protein, interferon alpha 2 Protein, interferon, alpha 2 Protein, interferon-alpha-2 Protein, interferon alpha-2 Protein, IFNA2 Protein, Ifna2 Protein, ifna2 Protein, IFN-ALPHA2 Protein, LOC102142148 Protein
- 分子量
- 18 kDa
- 途径
- JAK/STAT Signaling, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Hepatitis C
-
